Evaluation of the effective time for GSK-3 inhibition in experimental autoimmune encephalomyelitis mouse model by tideglusib (NP-12) in preventing neuroinflammation
Glycogen synthase kinase-3 (GSK-3) is an enzyme involved in various neurodegenerative and neuro-inflammatory diseases, including multiple sclerosis (MS) and its animal model of experimental autoimmune encephalomyelitis (EAE). The severity of the disease could be characterized by the degree of cel...
Main Author: | Al-Zaidi, Ahmed Salam |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/84211/1/FPSK%20%28m%29%202019%2033%20UPM%20ir.pdf |
Similar Items
-
Examining cognition and brain networks using magnetoencephalography in paediatric autoimmune encephalitis and acute disseminated encephalomyelitis: a preliminary study
by: Billaud, Charly Hugo Alexandre, et al.
Published: (2024) -
Differential time course of glycogen synthase kinase-3 inhibition in experimental autoimmune encephalomyelitis
by: Al-Zaidi, Ahmed Salam, et al.
Published: (2021) -
Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug-resistant epilepsy
by: Xiong, Wenzheng, et al.
Published: (2024) -
Inhibition of GSK-3 by Tideglusib suppresses activated macrophages and inflammatory responses in lipopolysaccharide-stimulated RAW 264.7 cell line
by: Zailan, Nur Fatin Zalikha, et al.
Published: (2020) -
Effects of GSK-3 inhibition on LPS-induced neuroinflammation and IL-10 production in microglia
by: Md Zain, Zuhaida
Published: (2016)